Transaction in Own Shares

Summary by AI BETAClose X

GSK plc announced the purchase of 180,000 of its own ordinary shares, with a nominal value of 31¼ pence each, on October 29, 2025. The shares were bought through BNP Paribas SA at prices ranging from 1,669.50p to 1,761.00p per share, with a volume-weighted average price of 1,720.61p. These shares will be held as Treasury shares, as part of an existing buyback program announced on September 30, 2025. Since that date, the company has purchased 6,948,500 ordinary shares. Following this transaction, GSK holds 254,413,344 ordinary shares in treasury and has 4,061,007,442 ordinary shares in issue, excluding treasury shares; the treasury shares represent 6.26 percent of voting rights.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings